Pneumonitis Clinical Trial
Official title:
Accurate Classification System for Patients With COVID-19 Based on Prognostic Nomogram
The COVID-19 has a clustering morbidity trend and older people with chronic diseases are more likely to die, such as chronic renal insufficiency and chronic cardiovascular disease. We set up a COVID-19 pneumonia grading scale. The COVID-19 score system was validated to predict the clinical outcome of a patient.
1. First we collect the medical records, according to the time sequence, the patients were
divided into two groups, one is the model group, and the other is the validate group.
2. Responsible for the risk factor of regression equation according to the model. The
patients were divided into three groups according to their total score of risk
responsibility.
3. Compared with SEPSIS and CURB-65 grading system with the grading system we established.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02246361 -
Impact of Six Patient Information Leaflets (PIL) on Doctor Patient Communication
|
Phase 4 | |
Completed |
NCT00997555 -
Prophylactic Bronchoscopy After Inhalation Injury in Burn Patients
|
N/A | |
Recruiting |
NCT05280873 -
Pirfenidone Combined With Methylprednisolone Versus Methylprednisolone in the Treatment of CIP
|
Phase 1 | |
Completed |
NCT00081315 -
Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer
|
Phase 2 | |
Active, not recruiting |
NCT04590547 -
GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19)
|
Phase 2 | |
Terminated |
NCT04370834 -
Tocilizumab for Patients With Cancer and COVID-19 Disease
|
Phase 2 | |
Completed |
NCT02788643 -
Study of Collagen IV and XIX in Bronchoalveolar Lavage, Pulmonary Aspiration and Bronchial Biopsies
|
||
Active, not recruiting |
NCT04326725 -
Proflaxis Using Hydroxychloroquine Plus Vitamins-Zinc During COVID-19 Pandemia
|
||
Completed |
NCT03012958 -
Utility of Lung Clearance Index Score as a Noninvasive Marker of Deployment Lung Disease
|
||
Completed |
NCT03730428 -
Everolimus Related Pneumonitis in MBC
|
||
Completed |
NCT04721444 -
Optimising Cancer Therapy And Identifying Causes of Pneumonitis USing Artificial Intelligence (COVID-19)
|
||
Terminated |
NCT04040244 -
Exhaled Breath Analysis to Predict Risk of Symptomatic Pneumonitis
|
N/A | |
Terminated |
NCT03962725 -
Avoiding Neuromuscular Blockers to Reduce Complications
|
Phase 4 | |
Recruiting |
NCT05455034 -
Single-cell Sequencing of BLF to Guide the Treatment of Radiation Pneumonitis or Immune Checkpoint Inhibitor Pneumonitis
|
Phase 1/Phase 2 |